nach oben

Hepatology International

Erschienen in:

20.04.2018 | Editorial

The growing burden of liver cirrhosis: implications for preventive measures

verfasst von: Martin C. S. Wong, Junjie Huang

Erschienen in: Hepatology International | Ausgabe 3/2018

Einloggen, um Zugang zu erhalten

Excerpt

Liver cirrhosis has become one of the major causes of morbidity and mortality. The Global Burden of Disease (GBD) reported that over one million people died due to cirrhosis in 2010 worldwide, compared with 676,000 deaths in 1980. Since the survival rate of cirrhosis is relatively low, data on the incidence of geographical variations are essential to prevent its related disability and mortality. However, the heavy burden of this medical condition might be even greater, as relevant data in 58/187 (31%) of countries were not available in the report [1]. …

Mokdad AA, Lopez AD, Shahraz S, Lozano R, Mokdad AH, Stanaway J, Murray C, Naghavi M. Liver cirrhosis mortality in 187 countries between 1980 and 2010: a systematic analysis. BMC Med. 2014. https://doi.org/10.1186/s12916-014-0145-y.PubMedPubMedCentralCrossRef

Byass P. The global burden of liver disease: a challenge for methods and for public health. BMC Med. 2014. https://doi.org/10.1186/s12916-014-0159-5.CrossRefPubMedPubMedCentral

Wong MC, Huang JL, George J, Huang J, Leung C, Eslam M, Chan HLY, Ng SC. The changing epidemiology of liver diseases in Asia-Pacific. Nat Rev Gastroenterol Hepatol. 2018 (accepted).

Rehm J, Taylor B, Mohapatra S, Irving H, Baliunas D, Patra J, Roerecke M. Alcohol as a risk factor for liver cirrhosis: a systematic review and meta-analysis. Drug Alcohol Rev. 2010;29(4):437–45. https://doi.org/10.1111/j.1465-3362.2009.00153.x.CrossRefPubMed

Nusrat S, Khan MS, Fazili J, Madhoun MF. Cirrhosis and its complications: evidence based treatment. World J Gastroenterol. 2014;20(18):5442. https://doi.org/10.3748/wjg.v20.i18.5442.CrossRefPubMedPubMedCentral

Wong MC, Jiang JY, Goggins WB, Liang M, Fang Y, Fung FD, Leung C, Wang HH, Wong GL, Wong VW, Chan HL. International incidence and mortality trends of liver cancer: a global profile. Sci Rep. 2017;31(7):45846. https://doi.org/10.1038/srep45846.CrossRef

Wong MC, Ching JY, Chan VC, Lam TY, Luk AK, Wong SH, Ng SC, Wong VW, Ng SS, Wu JC, Chan FK, Sung JJ. Screening strategies for colorectal cancer among patients with nonalcoholic fatty liver disease and family history. Int J Cancer. 2016;138(3):576–83. https://doi.org/10.1002/ijc.29809 Epub 2015 Sep 1.CrossRefPubMed

Schuppan D, Afdhal NH. Liver cirrhosis. The Lancet. 2018;371(9615):838–51. https://doi.org/10.1016/s0140-6736(08)60383-9.CrossRef

Chung W, Jo C, Chung WJ, Kim DJ. Liver cirrhosis and cancer: comparison of mortality. Hepatol Int. 2018. https://doi.org/10.1007/s12072-018-9850-5.PubMedCrossRef

10.

Williams R, Alexander G, Armstrong I, Baker A, Bhala N, Camps-Walsh G, Cramp ME, de Lusignan S, Day N, Dhawan A, Dillon J, Drummond C, Dyson J, Foster G, Gilmore I, Hudson M, Kelly D, Langford A, McDougall N, Meier P, Moriarty K, Newsome P, O’Grady J, Pryke R, Rolfe L, Rice P, Rutter H, Sheron N, Taylor A, Thompson J, Thorburn D, Verne J, Wass J, Yeoman A. Disease burden and costs from excess alcohol consumption, obesity, and viral hepatitis: fourth report of the Lancet Standing Commission on Liver Disease in the UK. Lancet. 2018. 391(10125):1097–107.CrossRefPubMed

11.

Williams R, Alexander G, Aspinall R, Bosanquet J, Camps-Walsh G, Cramp M, Day N, Dhawan A, Dillon J, Dyson J, Ferguson J, Foster G, Gardner R, Gilmore SI, Hardman L, Hudson M, Kelly D, Langford A, Liversedge S, Moriarty K, Newsome P, O’Grady J, Pryke R, Rolfe L, Rutter H, Ryder S, Samyn M, Sheron N, Taylor A, Thompson J, Verne J, Yeoman A. New metrics for the Lancet Standing Commission on Liver Disease in the UK. Lancet. 2017;389(10083):2053–80.CrossRefPubMed

12.

Williams R, Ashton K, Aspinall R, Bellis MA, Bosanquet J, Cramp ME, Day N, Dhawan A, Dillon J, Dyson J, Ferguson J, Foster G, Gilmore SI, Glynn M, Guthrie JA, Hudson M, Kelly D, Langford A, Newsome P, O’Grady J, Pryke R, Ryder S, Samyn M, Sheron N, Verne J. Implementation of the Lancet Standing Commission on Liver Disease in the UK. Lancet. 2015;386(10008):2098–111.CrossRefPubMed

13.

Williams R, Aspinall R, Bellis M, Camps-Walsh G, Cramp M, Dhawan A, Ferguson J, Forton D, Foster G, Gilmore I, Hickman M, Hudson M, Kelly D, Langford A, Lombard M, Longworth L, Martin N, Moriarty K, Newsome P, O’Grady J, Pryke R, Rutter H, Ryder S, Sheron N, Smith T. Addressing liver disease in the UK: a blueprint for attaining excellence in health care and reducing premature mortality from lifestyle issues of excess consumption of alcohol, obesity, and viral hepatitis. Lancet. 2014;384(9958):1953–97.CrossRefPubMed

Titel: The growing burden of liver cirrhosis: implications for preventive measures
verfasst von: Martin C. S. Wong
Junjie Huang
Publikationsdatum: 20.04.2018
Verlag: Springer India
Erschienen in: Hepatology International / Ausgabe 3/2018
Print ISSN: 1936-0533
Elektronische ISSN: 1936-0541
DOI: https://doi.org/10.1007/s12072-018-9865-y

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Innere Medizin

25.04.2024 | Hypotonie | Nachrichten

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

The growing burden of liver cirrhosis: implications for preventive measures

Excerpt

Leitlinien kompakt für die Innere Medizin

Neu im Fachgebiet Innere Medizin

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

Adjuvante Immuntherapie verlängert Leben bei RCC

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

Update Innere Medizin

Springer Medizin

Excerpt

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 3/2018

Beyond KCH selection and options in acute liver failure

Tsumura-Suzuki obese diabetic mice-derived hepatic tumors closely resemble human hepatocellular carcinomas in metabolism-related genes expression and bile acid accumulation

Glecaprevir/pibrentasvir expands reach while reducing cost and duration of hepatitis C virus therapy

Analysis of the high incidence of acute kidney injury associated with acute-on-chronic liver failure

Liver cirrhosis and cancer: comparison of mortality

Plasma miRNA-122-5p and miRNA-151a-3p identified as potential biomarkers for liver injury among CHB patients with PNALT

Leitlinien kompakt für die Innere Medizin

Neu im Fachgebiet Innere Medizin

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

Adjuvante Immuntherapie verlängert Leben bei RCC

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

Update Innere Medizin